SCHOTT Pharma AG & Co. KGaA Cash Flow-to-Debt Ratio
SCHOTT Pharma AG & Co. KGaA cash flow-to-debt ratio. SCHOTT Pharma AG & Co. KGaA (1SXP) has a Cash Flow-to-Debt Ratio of 0.12x as of September 2024, meaning its operating cash flow of €75.97 Million could theoretically repay 0% of its total liabilities (€650.00 Million) in one year. Check SCHOTT Pharma AG & Co. KGaA investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of SCHOTT Pharma AG & Co. KGaA (2020–2024)
Cash flow-to-debt ratio of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. Historical debt coverage capacity for SCHOTT Pharma AG & Co. KGaA across 5 annual periods. Check 1SXP operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
SCHOTT Pharma AG & Co. KGaA Cash Flow-to-Debt Ratio by Year (2020–2024)
SCHOTT Pharma AG & Co. KGaA cash flow-to-debt ratio by year from 2020 to 2024. Year-by-year debt coverage analysis for SCHOTT Pharma AG & Co. KGaA. For the full cash flow conversion analysis, see cash flow conversion of SCHOTT Pharma AG & Co. KGaA.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | €225.33 Million | €650.00 Million | ▲ +3.0% |
| 2023 | 0.34x | €181.65 Million | €539.65 Million | ▼ -9.9% |
| 2022 | 0.37x | €182.12 Million | €487.46 Million | ▼ -9.4% |
| 2021 | 0.41x | €132.21 Million | €320.48 Million | ▲ +10.8% |
| 2020 | 0.37x | €104.40 Million | €280.36 Million | — |